Literature DB >> 28552137

The natural history of cerebral arteriovenous malformations.

Anil Can1, Bradley A Gross1, Rose Du2.   

Abstract

Cerebral arteriovenous malformations (AVMs) are composed of a complex tangle of abnormal arteries and veins and are a significant source of cerebral hemorrhage and consequent morbidity and mortality in young adults, representing a diagnostic and therapeutic challenge. Current natural-history studies of cerebral AVMs report overall annual rates of 1% and 3% for the risk of epilepsy and hemorrhage, respectively. Unruptured AVMs have an annual hemorrhage rate of 2.2% while ruptured lesions have an annual hemorrhage rate of 4.5%. These hemorrhage rates are can change over time, particularly for hemorrhagic lesions, with the rebleed rate ranging from 6% to 15.8% in the first year after rupture across several studies. Besides hemorrhage, other significant risk factors for AVM hemorrhage include deep location, deep venous drainage, associated aneurysms, and pregnancy. Other factors include patient age, sex, and small AVM size, which are not currently considered significant risk factors for AVM hemorrhage. In addition to hemorrhage risk and seizure risk, the natural history of an AVM also encompasses the daily psychologic burden that a patient must endure knowing that he or she possesses an untreated AVM. This chapter reviews the epidemiology, clinical features, and natural history of cerebral AVMs.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  arteriovenous malformation; intracerebral hemorrhage; intraventricular hemorrhage; natural history; nidus; rebleeding; risk factor; stroke; subarachnoid hemorrhage; vascular malformation

Mesh:

Year:  2017        PMID: 28552137     DOI: 10.1016/B978-0-444-63640-9.00002-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  9 in total

1.  Long-term outcomes and prognostic predictors of 111 pediatric hemorrhagic cerebral arteriovenous malformations after microsurgical resection: a single-center experience.

Authors:  Zhenghai Deng; Yu Chen; Li Ma; Ruinan Li; Shuo Wang; Dong Zhang; Yuanli Zhao; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2020-02-20       Impact factor: 3.042

2.  European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Omer F Eker; Edoardo Boccardi; Ulrich Sure; Maneesh C Patel; Saverio Alicante; Ali Alsafi; Nicola Coote; Freya Droege; Olivier Dupuis; Annette Dam Fialla; Bryony Jones; Ujwal Kariholu; Anette D Kjeldsen; David Lefroy; Gennaro M Lenato; Hans Jurgen Mager; Guido Manfredi; Troels H Nielsen; Fabio Pagella; Marco C Post; Catherine Rennie; Carlo Sabbà; Patrizia Suppressa; Pernille M Toerring; Sara Ugolini; Elisabetta Buscarini; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

3.  Efficacy and safety of embolization for arteriovenous malformations of the basal ganglia and thalamus via the transarterial approach.

Authors:  Wei Zhang; Heng Wei; Qi Tian; Shoumeng Han; Wenrui Han; Yujia Guo; Guijun Wang; Shenqi Zhang; Gang Deng; Junming Wang; Qianxue Chen; Mingchang Li
Journal:  Ann Transl Med       Date:  2022-03

4.  External validation of brain arteriovenous malformation haemorrhage scores, AVICH, ICH and R2eD.

Authors:  Basel A Taweel; Conor S Gillespie; George E Richardson; Mohammad A Mustafa; Tamara Ali; Abdurrahman I Islim; Cathal J Hannan; Emmanuel Chavredakis
Journal:  Acta Neurochir (Wien)       Date:  2022-04-18       Impact factor: 2.816

5.  Image-guided robotic radiosurgery for the treatment of arteriovenous malformations.

Authors:  Franziska Loebel; Antonio Pontoriero; Anne Kluge; Giuseppe Iatì; Gueliz Acker; Markus Kufeld; Alberto Cacciola; Stefano Pergolizzi; Sergio Vinci; Sara Lillo; Ran Xu; Carmen Stromberger; Volker Budach; Peter Vajkoczy; Carolin Senger; Alfredo Conti
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

Review 6.  Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.

Authors:  David M Meredith; Sanda Alexandrescu
Journal:  Brain Pathol       Date:  2022-03-09       Impact factor: 7.611

Review 7.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

8.  Arteriovenous Malformation of the Cervical Spine Presenting as Subarachnoid Hemorrhage.

Authors:  Travis M Cox; Daniel M Chavez Andia; Gabriel Aisenberg
Journal:  Cureus       Date:  2020-03-07

9.  DELAYED DIAGNOSIS OF AVM PRESENTING WITH STROKE AND SEIZURES IN A YOUNG NIGERIAN: A CASE REPORT.

Authors:  A I Makanjuola; P Bolaji; C Onyejelam; G I Ogbole; R O Akinyemi
Journal:  Ann Ib Postgrad Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.